SleepImage offers a breakthrough in the sleep health industry with developments that make sleep disorder diagnosis and management easier than ever.
With the broadest FDA-clearance of any sleep test on the market for establishing sleep quality, measuring sleep duration, detecting sleep apnea, and managing sleep disorder treatments – SleepImage transforms the future of sleep health through research and innovation.
A Hybrid Solution With High-Level Clinical Accuracy
SleepImage has brought forth the first-ever sleep disorder breathing test that provides an extensive review of the following:
- Oxygen Saturation Index (ODI)
- Apnea Hypopnea Index (Central and Obstructive AHI)
- Respiratory Disturbance Index (RDI)
- Sleep Apnea Indicator (SAI)
This makes it a one-stop solution with proven high clinical accuracy. It provides a comprehensive overview of all the issues leading to sleep apnea and of the underlying health consequences of untreated sleep apnea (or of unsuccessful treatment).
State-of-the-Art Features Provide an In-Depth Look at Sleeping Patterns
The leading-edge SleepImage test produces comprehensive output and a complete “picture” of the sleep period, including NREM/REM study, providing an easy way to identify and interpret sleep pathologies. The following readings help with that evaluation:
- Oxygen desaturations (ODI and AHI)
- Autonomic arousals that break up sleep (RDI)
- Cardiovascular function through Cyclic Variation of Heart Rate during unstable sleep (SAI)
- An intuitive Sleep Quality Index reading for complete sleep health evaluation
These readings make physician/patient interactions easier and treatment tracking more meaningful. The Sleep Quality Index (SQI), ranging from 0 to 100, is a summary metrics of all the factors that contribute to sleep health – making it an intuitive way for both the clinician and the patient to evaluate the results and understand whether treatment is needed.
Cost-Effectiveness and Flexibility
This revolutionary sleep disorder test is cost-effective, doesn’t require any consumables, and is remarkably flexible in terms of the use of the hardware. Each recording device can be used either with multiple patients to screen and diagnose or by a single patient to monitor treatment over time.
The SleepImage System is essentially a Software as a Medical Device (SaMD), so it can be sold like other SaaS models that are low-cost and scalable. A service provider can craft custom pricing models that encourage multi-night testing – without increasing costs linearly with each additional test.
This is a huge step forward in the right direction and we hope to see more innovative solutions from SleepImage in the coming future.